The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bancroft, A. J.
Right arrow Articles by Grencis, R. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bancroft, A. J.
Right arrow Articles by Grencis, R. K.
The Journal of Immunology, 2004, 172: 7635-7641.
Copyright © 2004 by The American Association of Immunologists

WSX-1: A Key Role in Induction of Chronic Intestinal Nematode Infection1

Allison J. Bancroft2,*, Neil E. Humphreys*, John J. Worthington*, Hiroki Yoshida{dagger},{ddagger} and Richard K. Grencis*

* School of Biological Sciences, University of Manchester, Manchester, United Kingdom; {dagger} Division of Molecular and Cellular Immunoscience, Department of Biomolecular Sciences, Saga Medical School, Saga, Japan; and {ddagger} PRESTO, Japan Science and Technology Agency, Saitama, Japan


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Chronic infection by the gastrointestinal nematode Trichuris muris in susceptible AKR mice, which mount a Th1 response, is associated with IL-27p28 expression in the cecum. In contrast to wild-type mice, mice that lack the WSX-1/IL-27R gene fail to harbor a chronic infection, having significantly lower Th1 responses. The lower level of Ag-specific IFN-{gamma}-positive cells in WSX-1 knockout (KO) mice was found to be CD4+ T cell specific, and the KO mice also had increased levels of IL-4-positive CD4+ T cells. Polyclonal activation of mesenteric lymph node cells from naive WSX-1 KO or wild-type mice demonstrated that there was no inherent defect in the production of IFN-{gamma} by CD4+ T cells, suggesting the decrease in these cells seen in infected WSX-1 KO mice is an in vivo Ag-driven effect. IL-12 treatment of WSX-1 KO mice failed to rescue the type 1 response, resulting in unaltered type-2-driven resistance. Infection of WSX-1 KO mice was also associated with a reduction of IL-27/WSX-1 downstream signaling gene expression within the cecum. These studies demonstrate an important role for WSX-1 signaling in the promotion of type 1 responses and chronic gastrointestinal nematode infection.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Interleukin-27 is bound by WSX-1/type I cytokine receptor (TCCR),3 which is present mainly on CD4+ T cells (1, 2, 3, 4). It has recently been demonstrated that the IL-27/WSX-1 interaction leads to phosphorylation of STAT-1, which in turn induces expression of T-bet (5), a transcription factor previously shown to play a role in Th1 lineage commitment (6), including mucosal immune responses (7).

IL-27 is heterodimeric, being composed of p28 (IL-12p35-like) and EBI3 (IL-12p40-like). It has been shown to cause proliferation and IFN-{gamma} secretion in naive CD4+ T cells and NK cells (1). p28 and EBI3 were shown to have a highly restricted pattern of coexpression and are found together mainly on APCs. Importantly, bone-marrow-derived dendritic cells, when stimulated with LPS, showed expression of both p28 and EBI3 occurring before expression of IL-12p35 and IL-12p40, demonstrating that IL-27 may act very early on in Th subset differentiation (1).

WSX-1/TCCR knockout (KO) mice have been shown to have a profoundly reduced IFN-{gamma} response when infected with Leishmania major at 2 wk postinfection (p.i.), although by 6 wk p.i., IFN-{gamma} responses between KO and C57BL/6 wild-type (WT) mice were comparable, suggesting that IL-27/WSX-1 signaling may be less important for maintaining a Th1 response (4). However, two recent studies on Toxoplasma gondii and Trypanosoma cruzi have demonstrated that WSX-1 plays a role in limiting the intensity and duration of T cell activation, as WSX-1 KO mice infected with either parasite develop a lethal T cell-mediated inflammatory disease (8, 9).

Trichuris muris is a gastrointestinal nematode very closely related to the human counterpart Trichuris trichiura. The majority of inbred mouse strains expel T. muris from its large intestinal niche and make a dominant Th2 response (10, 11, 12). However, a few strains of mouse fail to expel T. muris, harbor a chronic infection, and generate an associated Th1 response (13, 14, 15). It has been previously observed that there is a predisposition to particular infection levels of T. trichiura and T. muris in humans and mice, respectively. Experimental manipulation of T. muris infection levels allows us to mimic low-level chronic infection (16), which is the norm in human populations.

What is abundantly clear is the failure to expel the parasite is not a failure to mount an immune response per se. Although a number of factors have been shown to play a role in the Th1/Th2 "decision making", it is arguably the cytokine environment at the time of Ag presentation that is one of the most important factors (17). A number of cytokines, genes, and transcription factors have been shown to be important in driving a type 1 response (18, 19, 20), however, the precise mechanisms that underlie initiation of this response in favor of a type 2 response remain unclear.

This paper is the first study to examine the IL-27/WSX-1 interaction in a chronic gastrointestinal nematode infection, showing a dramatic defect in the ability of WSX-1 KO mice to generate a type 1 response. This defect could not be compensated for by the addition of exogenous IL-12. Moreover, this study demonstrates an up-regulation of the genes involved with IL-27/WSX-1 signaling and subsequent activation of the IL-12 signaling cascade in chronic T. muris infection.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Mice

WSX-1 KO were generated as described previously (4) and backcrossed onto a C57BL/6 background >10 times. They were bred and maintained in the Biological Services Unit at University of Manchester (Manchester, U.K.). C57BL/6 WT, AKR, and BALB/c mice were purchased from Harlan Olac (Bicester, U.K.) and were infected when 6–8 wk old. Animal experiments were performed under the regulation of the Home Office Scientific Procedures Act (1986).

Parasites

Infection and maintenance of T. muris was conducted as described by Wakelin (21). Low-level infections were 25 T. muris eggs and high-level infections were ~100 T. muris eggs.

Parasite Ag

Adult worms were cultured in RPMI 1640 (Invitrogen, Paisley, U.K.) and excretory-secretory (ES) Ag was collected after 4 h and overnight culture. The ES was prepared as in Ref.16 .

In vitro cytokine analysis

Mesenteric lymph node cell (MLNC) suspensions from infected or control mice were prepared as described previously (9). Briefly, 5 x 106 cells/ml were resuspended in RPMI 1640, 10% FCS, 2 mM L-glutamine, 100 U/ml penicillin, and 100 µg/ml streptomycin (Invitrogen). MLNC were stimulated with 50 µg/ml T. muris for 4 h ES Ag in 24-well plates (Costar, Cambridge, MA). Supernatants were harvested at 24 h.

Supernatants were analyzed for cytokine content by sandwich ELISA as previously described (10). The mAbs used were 11B11 and 24G.2 for IL-4, TRFK-5 and TRFK-4 for IL-5, 229.4 (E. Schmitt, Johannes Gutenberg-University of Mainz, Mainz, Germany) and 2C12 for IL-9, R46A2 and XMG1.2 for IFN-{gamma}, and C15.6 and C17.8 for IL-12p40 (all from BD PharMingen, San Diego, CA). IL-13 was measured using a kit (R&D Systems, Minneapolis, MN).

Ab ELISAs

Levels of parasite-specific IgG1 and IgG2a Ab were determined by ELISA and conducted as described in Ref.22 . Briefly, Immulon IV ELISA plates (Dynal Biotech, Oslo, Norway) were coated with T. muris ES overnight Ag at 5 µg/ml. Serum was diluted from 1/20 to 1/2560, and parasite-specific IgG1 was detected with biotinylated anti-mouse IgG1 (Serotec, Oxford, U.K.) and biotinylated anti-mouse IgG2a (BD PharMingen).

IL-12 treatment

One microgram of murine rIL-12 in 0.2 ml of PBS was given i.p. every second day from day 0 to 14 p.i. Controls received PBS.

Intracellular cytokine staining

MLNC were restimulated for 24 h at 37°C with ES for IFN-{gamma} and IL-4 staining. PMA (50 ng/ml) and ionomycin (500 ng/ml) was added for the last 3 h of culture for IL-4 staining only. Brefeldin A (1 µg/ml; Sigma-Aldrich, St. Louis, MO) was added for the final 1.5 h of culture. After washing, cells were stained for surface markers (CD4-FITC (RM4-5) or CD8-PE (53-6.7)) for 30 min at 4°C, fixed in 2% formaldehyde for 20 min, and washed in 0.1% saponin. Anti-cytokine Abs were then added, either anti-IL-4 (11B11) conjugated to allophycocyanin or biotinylated anti-IFN-{gamma} (XMG1.2) (BD PharMingen). IFN-{gamma}-stained cells were further incubated with streptavidin-allophycocyanin (Caltag Laboratories, Burlingame, CA). The cells were analyzed on a FACSCalibur using CellQuest Pro software (BD Biosciences, Mountain View, CA).

CFSE labeling

Five micromolars CFSE were added for 15 min to MLNC at 5 x 106 cells/ml, and 100 µl of FCS/ml cells were added to quench the reaction. Cells were cultured for 96 h under Th0-, Th1-, or Th2-polarizing conditions. IFN-{gamma} CD4+ T cells were identified and, using CFSE fluorescence intensity, further subdivided into populations that had undergone 0–7 divisions.

In vitro polarizing conditions

Plate-bound anti-CD3{epsilon} (2C11) at 3 µg/ml and soluble anti-CD28 (CD28.2; BD PharMingen) at 10 µg/ml were added to all cultures. Th1 polarization was induced by addition of 5 ng/ml rIL-12 and 20 µg/ml anti-murine IL-4 mAb (11B11). Th2 polarization was induced by addition of 50 ng/ml murine rIL-4 and 50 µg/ml anti-IFN-{gamma} mAb (XMG1.2). Cocultures were harvested after 24, 48, and 72 h for cytokine analysis and after 96 h to assess proliferating IFN-{gamma}-positive cells by FACS analysis.

RT-PCR

The cecal tip and the MLN were removed from both WSX-1 KO and WT mice at day 21 p.i. and snap frozen in 1 ml of TRIzol. After homogenization, mRNA was prepared and assessed for quality by spectrophotometry at 260 nm and visualization of 18s and 28s ribosomal bands on a 2% agarose gel. Two microliters of mRNA was reverse transcribed using Improm II and Oligo(dT) (Promega, Madison, WI). cDNA (0.4 µg) was used in a 20-µl PCR. The primer sequences were as follows: WSX-1, 5'-ACCATTGGAGTATGTGGTGGACTG, 5'-CTCCTTGATGTAAGGTTGCCCAGA; p28, 5'–TGACTCTGAGAGACTCTGCTTCCT, 5'-TTCCTCCTCTTCCTCTTCCTCCTT; EBI3, 5'-ACCCTCTCTCTGATGGGTCACTAA, 5'-AGAAAGATCATCCCACAGGGTTGG; STAT-1, 5'-AGAAATTCACCTATGAGCCCGACC, 5'-TCCATGGAATAAGACCATCAGGGC; T-bet, 5'-AACCGCTTATATGTCCACCCAGAC, 5'-CTCGGAACTCCGCTTCATAACTGT; and IL-12R{beta}2, 5'-CCCTCACATTACTGCCATCACAGA, 5'-GCTGTGAGAGTTCCTGTAGCTTGT.

Statistical analysis

Statistical analysis was conducted using the Mann-Whitney U test. A value of p < 0.05 was considered to be significant.


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
IL-27/WSX-1 signaling is associated with chronic T. muris infection and WSX-1 KO mice are resistant to infection, making reduced Th1 responses

WSX-1 was first described as a cytokine receptor important for driving type 1 responses and IFN-{gamma} production. To examine whether signaling through WSX-1 is important in the Th1-associated chronic T. muris infection, gene expression at the initial site of Ag encounter was examined. Fig. 1a shows the cecal expression of genes involved in IL-27/WSX-1 signaling at day 21 p.i. from both susceptible (AKR) and resistant (BALB/c) mice. T. muris is intimately associated with the cecal epithelium. EBI3 and WSX-1 are both expressed in AKR and BALB/c mice, whereas p28, T-bet, and IL-12R{beta}2 are absent and STAT-1 is expressed at a reduced level in resistant BALB/c mice.



View larger version (39K):
[in this window]
[in a new window]
 
FIGURE 1. The IL-27/WSX-1 signaling pathway is associated with chronic infection and WSX-1 KO mice are resistant to chronic T. muris infection, making reduced Th1 responses. a, RT-PCR of genes associated with the IL-27/WSX-1 signaling pathway in the cecum at day 21 p.i. using three mice per group. WSX-1 KO () and C57BL/6 mice ({blacksquare}) (n = 4) were infected with a low-level T. muris infection. b, Mean worm burden at day 19 and 35 p.i. c, The relative levels of parasite-specific IgG1 (G1) and IgG2a (G2a) present in a 1/80 dilution of serum taken from mice at day 35 p.i. d, iiv, Ag-specific cytokine production at day 19 p.i. when MLNC were restimulated in vitro for 24 h with 50 µg/ml parasite Ag. *, Significantly different (p < 0.05) from WT mice; KO, WSX-1 KO mice.

 
Infection was next conducted in WSX-1 KO and WT C57BL/6 mice. Fig. 1b demonstrates infection data from WSX-1 KO and WT C57BL/6 mice at day 19 (day 18–21 p.i. is the time of optimal cytokine production) and day 35 p.i. (used to confirm resistance and susceptibility as the parasite is sexually mature). Both WSX-1 KO mice and C57BL/6 mice were infected with a low-level infection, which has previously been shown to change the response phenotype of resistant mice (23). It is clear that at both time points worms were obtained from WT C57BL/6 mice, whereas WSX-1 KO mice had expelled their parasites.

Fig. 1c demonstrates Ag-specific Ab production at day 35 p.i. from both WSX-1 KO and WT C57BL/6 mice. It can be seen that WSX-1 KO mice have significantly lower levels of parasite-specific IgG2a (p < 0.05) (which is dependent on IFN-{gamma} (24)) in comparison to infected WT mice. WSX-1 KO mice had similar levels of parasite-specific IgG1 when compared with infected WT mice.

Ag-specific cytokine production is shown in Fig. 1d, where it can be seen that WSX-1 KO mice make significantly reduced levels of type-1-associated cytokines (IFN-{gamma} and IL-12p40; p < 0.05) and significantly enhanced levels of type 2 cytokines (IL-4 and IL-13; p < 0.05). Similar data were obtained for IL-9, although there was no difference between infected KO and WT mice for IL-5 (data not shown). Infection of WSX-1 KO mice supports a role for signaling through IL-27/WSX-1 in chronic T. muris infection, as KO mice expelled their worms and failed to make type 1 responses associated with chronic infection.

Ag-driven reduction in IFN-{gamma}-positive CD4+ T cells

In an attempt to elucidate whether the lowered IFN-{gamma} production was of CD4 or CD8 cell origin, intracellular IFN-{gamma} staining was conducted on both CD4 and CD8 cells. Fig. 2 shows ex vivo cells from infected WSX-1 KO and WT mice at day 19 p.i. It can be seen that the lack of WSX-1 on the T cell causes a significant reduction in Ag-specific IFN-{gamma}-positive cells within the CD4+ T cell compartment (Fig. 2a; p < 0.05), with no significant difference observed in CD8+ T cells between KO and WT mice (Fig. 2b). IL-4-positive CD8+ cells were undetectable but there was a significant increase in IL-4-positive CD4+ T cells in WSX-1 KO mice compared with WT mice (Fig. 2c; p < 0.05).



View larger version (45K):
[in this window]
[in a new window]
 
FIGURE 2. Ag-driven reduction in IFN-{gamma}-positive CD4+ T cells. Intracellular FACS staining was conducted on four individual animals per group at day 19 p.i. For IFN-{gamma} staining (ai and bi) MLNC were restimulated in vitro with 50 µg/ml parasite Ag only. For IL-4 staining, ES plus PMA/ionomycin was used (ci). aii–cii, The amount of positively stained cells for one representative mouse per group. *, Significantly different (p < 0.05) from WT mice.

 
Paradoxically, Fig. 3 shows that significantly more IFN-{gamma} is produced by naive cells from WSX-1 KO mice when stimulated polyclonally in vitro under Th0-, Th1-, or Th2-polarizing conditions (ai–ci). Moreover, a significantly higher proportion of IFN-{gamma}-positive CD4+ T cells, which proliferated faster, were seen from WSX-1 KO mice again under all polarizing conditions (p < 0.05; aii–cii). This agrees with data from others that show that after polyclonal stimulation these mice have the ability to produce IFN-{gamma} in vitro (2).



View larger version (36K):
[in this window]
[in a new window]
 
FIGURE 3. Increase in IFN-{gamma}-positive CD4+ T cells after polyclonal stimulation in naive WSX-1 KO mice. MLNC from naive WSX-1 KO were cultured under Th0 (a), Th1 (b), and Th2 (c) conditions. aici, ELISA data from cells cultured for 24, 48, and 72 h. aiicii, The proliferation of CFSE-labeled cells from representative animals; aiiiciii, the mean percentage of IFN-{gamma}+CD4+ cells at each cell division, n = 5. •, WSX-1 KO; {circ}, WT mice; *, Significantly different (p < 0.05) from WT mice.

 
Exogenous IL-12 fails to drive chronic infection in WSX-1 KO mice

As WSX-1 was initially shown to be important for early T cell responses, it was thought that IL-12 may be able to compensate for the lack of WSX-1. Fig. 4a shows worm burden at day 35 p.i. from WSX-1 KO mice and C57BL/6 WT mice treated with either rIL-12 or PBS as a control. IL-12-treated WSX-1 KO mice failed to support a patent chronic infection. To ensure that the IL-12 treatment was able to modulate an effective Th2 response toward a Th1 response (as WT mice given a low-level infection already make a type 1 response), a high-level infection (Th2 inducing) was given to WT mice and then treated with IL-12. Fig. 4b shows that IL-12 treatment does indeed drive a high-level infection to chronicity in WT mice (p < 0.05). Intriguingly, Fig. 4c shows the parasite-specific IgG2a response in infected WSX-1 KO treated with IL-12 was elevated, indicating that IL-12 treatment did alter the Ab isotype response, despite data showing no elevation of the Th1 response (Fig. 4d). To further confirm rIL-12 was unable to affect the T cell response, the prevalence of IFN-{gamma}+CD4+ and CD8+ cells within the MLN was assessed. The percentage of Ag-restimulated IFN-{gamma}+CD4+ cells (0.58 ± 0.16% plus IL-12 vs 0.56 ± 0.05% minus IL-12) and IFN-{gamma}+CD8+ cells (0.97 ± 0.28% plus IL-12 vs 0.55 ± 0.07% minus IL-12) again showed no significant increase in response to the rIL-12 regime.



View larger version (44K):
[in this window]
[in a new window]
 
FIGURE 4. Exogenous IL-12 fails to drive chronic infection in WSX-1 KO mice. a, Mean day 35 p.i. worm burden from low-level T. muris-infected WSX-1 KO () and C57BL/6 WT ({blacksquare}) mice. *, Significantly different from WT mice; {dagger}, stunted worms. b, Mean worm burden at day 35 p.i. from C57BL/6 WT mice given a high-level infection and receiving either rIL-12 or PBS. c, Parasite-specific IgG2a from WSX-1 KO and WT mice given a low-level T. muris infection. d, Day 19 p.i., Ag-specific cytokine production when MLNC were restimulated in vitro for 24 h with 50 µg/ml parasite Ag from infected WSX-1 KO mice receiving either rIL-12 ({blacksquare}) or PBS (). e, Day 19 p.i., Ag-specific cytokine production from infected C57BL/6 WT mice given a high-dose infection (HD, {blacksquare}) and WSX-1 KO given a low-dose (LD, ) T. muris infection; n = 4 mice/group. IL-4, IL-5, and IL-9 are measured in units per milliliter, and IL-12p40, IL-13, and IFN-{gamma} are in nanograms per milliliter. f, RT-PCR of cecum and MLN from WSX-1 KO mice and C57BL/6 WT mice given a low-dose infection. Samples were taken at day 21 p.i.; n = 3 mice/group.

 
A possibility existed that IL-12-treated WSX-1 KO mice were making competent Th1 responses but excessive Th2 responses were eliminating the worms. Fig. 4d demonstrates that this was not the case and that there is no significant difference (p > 0.05) between the levels of Ag-specific cytokine production seen in WSX-1 KO mice (Th1 or Th2) with IL-12 treatment.

In a further attempt to show WSX-1 KO mice were not displaying exaggerated Th2 responses in our system, a comparison of Ag-specific, in vitro cytokine production between MLNC from WT mice given a high-dose infection and WSX-1 KO mice given a low-dose infection is shown in Fig. 4e. As both strains expel their worms effectively, it was interesting to note that comparable levels of Th2 cytokines were produced. Although levels of IL-4 are greater in the WSX-1 KO mice compared with WT mice (63.0 U/ml compared with 37.2 U/ml, respectively), the principal difference in the cytokine response is found in the residual IFN-{gamma} levels, with a 13-fold reduction observed in WSX-1 KO animals.

Down-regulation of the IL-27/WSX-1 signaling pathway in the cecum of infected WSX-1 KO mice

Gene expression analysis confirmed disrupted IL-27/WSX-1 signaling pathways in vivo in WSX-1 KO compared with WT mice given a low-dose infection. Unsurprisingly, WSX-1 expression was observed in the MLN and the cecum of WT but not WSX-1 KO mice (Fig. 4f). STAT-1 and EBI3 had less intense bands in the cecum of infected WSX-1 KO compared with C57BL/6 mice, and both p28 and T-bet were absent in the WSX-1 KO cecal samples. All these genes were expressed in the MLN, in the case of EBI3 and STAT-1 at similar levels, and to a lower level in the case of p28 and T-bet. IL-12R{beta}2 expression was observed only in the MLN of infected WT mice.


    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
We have shown that the genes involved in the IL-27/WSX-1 interaction and subsequent initiation of the IL-12 cytokine signaling cascade are present in a strain of mouse that is susceptible to T. muris, e.g., AKR, whereas in contrast, genes within this pathway are either absent or expressed to a lower extent in mice that expel their worms and are resistant to infection (Fig. 1a). In WSX-1 KO mice, in which clearly this pathway is interrupted at the initial stage, then there is a failure to establish chronic infection, and a subsequent down-regulation in type 1 responses. Ag-specific cytokine production (Fig. 1d) shows that in comparison to infected C57BL/6 WT mice, infected WSX-1 KO mice had reduced levels of both IFN-{gamma} and IL-12p40 and raised levels of IL-4 and IL-13. Raised levels of type 2 cytokines have been observed in TCCR KO mice immunized with keyhole limpet hemocyanin (and, interestingly in this case, IL-5 levels were also unaffected) (3). This demonstrates that WSX-1 is important for progression to chronic T. muris infection and associated Th1 responses.

Ex vivo CD4+ T cells from infected WSX-1 KO mice and WT C57BL/6 mice revealed a reduced number of IFN-{gamma}-positive Ag-activated CD4+ T cells in WSX-1 KO mice compared with WT mice (Fig. 2). WSX-1 has been shown to be present mainly on CD4+ cells and NKT cells, although unlike CD4+ T cells, NKT cells have previously been shown not to play an important role during T. muris infection (25). However, when naive cells were taken from both WSX-1 KO mice and WT C57BL/6 mice and stimulated in vitro under Th0-, Th1-, or Th2-polarizing conditions, it was shown under all conditions that WSX-1 KO mice produced higher levels of IFN-{gamma}-positive CD4+ T cells that proliferated faster than similar cells from WT mice (Fig. 3). Comparison between Figs. 2 and 3 highlights the differences between in vitro and ex vivo studies, and suggests that polyclonal stimulation does not necessarily reflect Ag-driven events, and raises the possibility that as yet undefined costimulatory events subtly influence the outcome of WSX-1/IL-27 interactions in vivo.

Treatment of WSX-1 KO mice with IL-12 failed to reverse their defect in their ability to harbor a chronic infection and low level of IFN-{gamma} and IL-12p40 production. Surprisingly, the administration of IL-12 at a dosage regime that readily promotes susceptibility in WT mice failed to do so in WSX-1 KO mice. This supports the hypothesis that WSX-1 is critical to Th1 responses and consequent susceptibility to infection.

Although recent studies have demonstrated that WSX-1 plays a role in limiting the intensity and duration of T cell activation and WSX-1 KO mice show enhanced Th2 responses rather than a defect in Th1 responses (8, 9), we feel this is not the case in our system. The differences between those studies and ours may reflect that WSX-1 has a dual role both in initiation and regulation of T cell responses. In addition, both CD8 and NK cells, together with CD4 cells, have been shown to be important in resistance to T. gondii and T. cruzi infections. However, with T. muris infection, resistance is exclusively CD4 cell mediated (26).

Comparison of two models of resistance, i.e., WSX-1 KO mice given a low-level infection and WT C57BL/6 mice given a high-level infection, demonstrated comparable levels of type 2 cytokine production. Although IL-4 levels were higher in the KO mice, the principal difference was in the reduced level of IFN-{gamma} production from WSX-1 KO mice. Crucially, IL-13, the key type 2 cytokine responsible for IL-4-independent resistance (27), generated after high-dose infection in WT mice is similar to that seen after a low-dose infection in WSX-1 KO mice. This argues that the inability of IL-12 to change the outcome of infection in WSX-1 KO mice is related to a defect in the immunoregulatory mechanisms operating in vivo, namely the generation of type 1 immunity.

It has recently been demonstrated that the IL-27/WSX-1 interaction leads to phosphorylation of STAT-1, which in turn induces expression of T-bet (5). Recent work has also shown that IL-27 regulates the responsiveness of naive CD4 cells through STAT-1-dependent and -independent mechanisms (28). The present data show a low level or absence in the gene expression of transcription factors downstream of IL-27/WSX-1 signaling in the cecum of resistant WSX-1 KO mice (Fig. 4f). In addition to explaining why IL-12 failed to rescue the WSX-1 KO (as IL-12R{beta}2 was undetectable in these mice), it is likely that down-regulation of this pathway is associated more generally with naturally induced Th2 responses (and not an artifact of knocking out the WSX-1 gene) as a similar pattern of gene expression was observed in resistant BALB/c mice given a high-dose infection (Fig. 1).

It is clear that the IL-27/WSX-1 interaction occurs early on in the immune response and probably there are a number of type-1-promoting transcription factors that may play an important role in chronic infection, e.g., suppressor of cytokine signaling proteins, class II transactivator, friend of GATA-1, and Runx1 (17, 18, 19, 29), although their relationship to WSX-1 is as yet undefined. Moreover, recent evidence is emerging demonstrating that Toll-like receptor (TLR) signaling pathways play an important role in determining the outcome of T. muris infection. In that study, it was shown C3HeJ mice (that cannot signal through TLR4), TLR4 KO mice, or myeloid differentiation factor 88 KO mice are not susceptible to chronic T. muris infection, and show depressed type 1 responses compared with susceptible WT mice (30). Therefore, it would be envisaged that IL-27/WSX-1 signaling may play an important part of the bridge between the innate and adaptive immune responses to T. muris and, furthermore, commitment to a chronic infection occurs early after initial Ag encounter, with susceptibility not simply being the subsequent down-modulation of a type 2 response. An understanding of the role of IL-27/WSX-1 in the regulation of type-2-mediated pathologies such as allergic inflammation is clearly important; the present data also confirm an important in vivo role for WSX-1/IL-27 in type-1-mediated responses following gastrointestinal nematode infection, and may be involved in type-1-mediated pathological conditions such as inflammatory bowel disease and autoimmunity.


    Acknowledgments
 
We are grateful to C. Maliszweski (Immunex, Seattle, WA) for the M1 anti-IL-4R mAb, and to J. Sypek (Wyeth, Andover, MA) for rIL-12.


    Footnotes
 
1 A.J.B. and N.E.H. are funded by The Wellcome Trust (Grant Number 44494/Z/95/Z and 062378/Z/00/Z). Back

2 Address correspondence and reprint requests to Dr. Allison J. Bancroft, School of Biological Sciences, 3.239 Stopford Building, University of Manchester, Oxford Road, Manchester, M13 9PT, U.K. E-mail address: allison.j.bancroft{at}man.ac.uk Back

3 Abbreviations used in this paper: TCCR, type I cytokine receptor; KO, knockout; ES, excretory-secretory; MLNC, mesenteric lymph node cells; p.i., postinfection; TLR, Toll-like receptor; WT, wild type. Back

Received for publication January 30, 2004. Accepted for publication April 14, 2004.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Pflanz, S., J. C. Timans, J. Cheung, R. Rosales, H. Kanzler, J. Gilbert, L. Hibbert, T. Churakov, M. Travis, E. Vaisberg, et al 2002. IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4+ T cells. Immunity 16:779.[Medline]
  2. Sprecher, C. A., F. J. Grant, J. W. Baumgartner, S. R. Presnell, S. K. Schrader, T. Yamagiwa, T. E. Whitmore, P. J. O’Hara, D. F. Foster. 1998. Cloning and characterization of a novel class I cytokine receptor. Biochem. Biophys. Res. Commun. 256:82.
  3. Chen, Q., N. Ghilardi, H. Wang, T. Baker, M.-H. Xie, A. Gurney, I. S. Grewal, F. J. de Sauvage. 2000. Development of Th-1 type immune responses requires the type 1 cytokine receptor TCCR. Nature 407:916.[Medline]
  4. Yoshida, H., S. Hamano, G. Senaldi, T. Covey, R. Faggioni, S. Mu, M. Xia, A. C. Wakeham, H. Nishina, J. Potter, et al 2001. WSX-1 is required for the initiation of Th1 responses and resistance to L. major infection. Immunity 15:569.[Medline]
  5. Takeda, A., S. Hamano, A. Yamanaka, T. Hanada, T. Ishibashi, T. W. Mak, A. Yoshimura, H. Yoshida. 2003. Cutting edge: role of IL-27/WSX-1 signaling for induction of T-bet through activation of STAT1 during initial Th1 commitment. J. Immunol. 170:4886.[Abstract/Free Full Text]
  6. Szabo, S. J., S. T. Kim, G. L. Costa, X. Zhang, C. G. Fathman, L. H. Glimcher. 2000. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 100:655.[Medline]
  7. Weigmann, B., M. F. Neurath. 2002. T-bet and mucosal responses in the gastro-intestinal tract. Gut 51:301.[Free Full Text]
  8. Villarino, A., L. Hibbert, L. Lieberman, E. Wilson, T. Mak, H. Yoshida, R. Kastelein, C. Saris, C. A. Hunter. 2003. The IL-27R (WSX-1) is required to suppress T cell hyperactivity during infection. Immunity 19:645.[Medline]
  9. Hamano, S., K. Himeno, Y. Miyazaki, K. Ishii, A. Yamanaka, A. Takeda, M. Zhang, H. Hisaeada, T. W. Mak, A. Yoshimura, H. Yoshida. 2003. WSX-1 is required for resistance to Trypanosoma cruzi infection by regulation of proinflammatory cytokine production. Immunity 19:657.[Medline]
  10. Else, K. J., R. K. Grencis. 1991. Cellular immune responses to the murine nematode parasite Trichuris muris. I. Differential cytokine production during acute or chronic infection. Immunology 72:508.[Medline]
  11. Else, K. J., L. Hültner, R. K. Grencis. 1992. Cellular immune responses to the murine nematode parasite Trichuris muris. II. Differential induction of TH-cell subsets in resistant versus susceptible mice. Immunology 75:232.[Medline]
  12. Bancroft, A. J., A. N. McKenzie, R. K. Grencis. 1998. A critical role for IL-13 in resistance to intestinal nematode infection. J. Immunol. 160:3453.[Abstract/Free Full Text]
  13. Else, K. J., F. D. Finkelman, C. R. Maliszewski, R. K. Grencis. 1994. Cytokine-mediated regulation of chronic intestinal helminth infection. J. Exp. Med. 179:347.[Abstract/Free Full Text]
  14. Bancroft, A. J., K. J. Else, J. P. Sypek, R. K. Grencis. 1997. Interleukin-12 promotes a chronic intestinal nematode infection. Eur. J. Immunol. 27:866.[Medline]
  15. Helmby, H., K. Takeda, S. Akira, R. K. Grencis. 2001. Interleukin (IL)-18 promotes the development of chronic gastrointestinal helminth infection by downregulating IL-13. J. Exp. Med. 194:355.[Abstract/Free Full Text]
  16. Bancroft, A. J., K. J. Else, N. E. Humphreys, R. K. Grencis. 2001. The effect of challenge and trickle Trichuris muris infections on the polarisation of the immune response. Int. J. Parasitol. 31:1627.[Medline]
  17. Gajewski, T. F., F. W. Fitch. 1988. Anti-proliferative effect of IFN-{gamma} in immune regulation. I. IFN-{gamma} inhibits the proliferation of Th2 but not Th1 murine helper T lymphocyte clones. J. Immunol. 140:4245.[Abstract]
  18. Alexander, W. S., R. Starr, J. E. Fenner, C. L. Scott, E. Handman, N. S. Sprigg, J. E. Corbin, A. L. Cornish, R. Darwiche, C. M. Owczarek, et al 1999. SOCS1 is a critical inhibitor of IFN-{gamma} signaling and prevents the potentially fatal neonatal actions of this cytokine. Cell 98:597.[Medline]
  19. Gourley, T., S. Roys, N. W. Lukacs, S. L. Kunkel, R. A. Flavell, C.-H. Chang. 1999. A novel role for the major histocompatibility complex class II transactivator CIITA in the repression of IL-4 production. Immunity 10:377.[Medline]
  20. Zhou, M., W. Ouyang, Q. Gong, S. G. Katz, J. M. White, S. H. Orkin, K. M. Murphy. 2001. Friend of GATA-1 represses GATA-3-dependent activity in CD4 T cells. J. Exp. Med. 194:1461.[Abstract/Free Full Text]
  21. Wakelin, D.. 1967. Acquired immunity to Tichuris muris in the albino laboratory mouse. Parasitology 57:515.[Medline]
  22. Else, K. J., G. M. Entwistle, R. K. Grencis. 1993. Correlations between worm burden and markers of Th1 and Th2 cell subset induction in an inbred strain of mouse infected with Trichuris muris. Parasite Immunol. 15:595.[Medline]
  23. Bancroft, A. J., K. J. Else, R. K. Grencis. 1994. Low-level infection with Trichuris muris significantly affects the polarization of the CD4 response. Eur. J. Immunol. 24:3113.[Medline]
  24. Finkelman, F. D., J. Holmes, I. M. Katona, J. F. Urban, Jr, M. P. Beckman, L. S. Parks, K. A. Schooley, R. L. Coffman, T. R. Mosmann, W. E. Paul. 1990. Lymphokine secretion of in vivo immunoglobulin isotype selection. Annu. Rev. Immunol. 8:303.[Medline]
  25. Koyama, K.. 2002. NK1.1 cell depletion in vivo fails to prevent protection against infection with the murine nematode Trichuris muris. Parasite Immunol. 24:527.[Medline]
  26. Else, K. J., R. K. Grencis. 1996. Antibody-independent effector mechanisms in resistance to the intestinal nematode parasite Trichuris muris. Infect. Immun. 64:2950.[Abstract]
  27. Bancroft, A. J., D. Artis, D. D. Donaldson, J. P. Sypek, R. K. Grencis. 2000. Gastrointestinal nematode expulsion in IL-4 knockout mice is IL-13 dependent. Eur. J. Immunol. 30:2083.[Medline]
  28. Lucas, S., N. Ghilardi, J. Li, F. J. de Sauvage. 2003. IL-27 regulates IL-12 responsiveness of naïve CD4+ T cells through Stat1-dependent and –independent mechanisms. Proc. Natl. Acad. Sci. USA 100:15047.[Abstract/Free Full Text]
  29. Komine, O., K. Hayashi, W. Natsume, T. Watanabe, Y. Seki, N. Seki, R. Yagi, W. Sukzuki, H. Tamauchi, K. Hozumi, et al 2002. The Runx1 transcription factor inhibits the differentiation of naïve CD4 T cells into the Th2 lineage by repressing GATA3 expression. J. Exp. Med. 198:51.
  30. Helmby, H., R. K. Grencis. 2003. Essential role for TLR4 and MyD88 in the development of chronic intestinal nematode infection. Eur. J. Immunol. 33:2974.[Medline]



This article has been cited by other articles:


Home page
J. Immunol.Home page
M. G. Nair, K. J. Guild, Y. Du, C. Zaph, G. D. Yancopoulos, D. M. Valenzuela, A. Murphy, S. Stevens, M. Karow, and D. Artis
Goblet Cell-Derived Resistin-Like Molecule {beta} Augments CD4+ T Cell Production of IFN-{gamma} and Infection-Induced Intestinal Inflammation
J. Immunol., October 1, 2008; 181(7): 4709 - 4715.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
N Sugiyama, H Nakashima, T Yoshimura, A Sadanaga, S Shimizu, K Masutani, T Igawa, M Akahoshi, K Miyake, A Takeda, et al.
Amelioration of human lupus-like phenotypes in MRL/lpr mice by overexpression of interleukin 27 receptor {alpha} (WSX-1)
Ann Rheum Dis, October 1, 2008; 67(10): 1461 - 1467.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
A. V. Villarino, D. Artis, J. S. Bezbradica, O. Miller, C. J. M. Saris, S. Joyce, and C. A. Hunter
IL-27R deficiency delays the onset of colitis and protects from helminth-induced pathology in a model of chronic IBD
Int. Immunol., June 1, 2008; 20(6): 739 - 752.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
M. G. Shainheit, R. Saraceno, L. E. Bazzone, L. I. Rutitzky, and M. J. Stadecker
Disruption of Interleukin-27 Signaling Results in Impaired Gamma Interferon Production but Does Not Significantly Affect Immunopathology in Murine Schistosome Infection
Infect. Immun., June 1, 2007; 75(6): 3169 - 3177.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. Yoshimura, A. Takeda, S. Hamano, Y. Miyazaki, I. Kinjyo, T. Ishibashi, A. Yoshimura, and H. Yoshida
Two-Sided Roles of IL-27: Induction of Th1 Differentiation on Naive CD4+ T Cells versus Suppression of Proinflammatory Cytokine Production Including IL-23-Induced IL-17 on Activated CD4+ T Cells Partially Through STAT3-Dependent Mechanism
J. Immunol., October 15, 2006; 177(8): 5377 - 5385.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
F. Larousserie, P. Charlot, E. Bardel, J. Froger, R. A. Kastelein, and O. Devergne
Differential Effects of IL-27 on Human B Cell Subsets
J. Immunol., May 15, 2006; 176(10): 5890 - 5897.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Miyazaki, H. Inoue, M. Matsumura, K. Matsumoto, T. Nakano, M. Tsuda, S. Hamano, A. Yoshimura, and H. Yoshida
Exacerbation of Experimental Allergic Asthma by Augmented Th2 Responses in WSX-1-Deficient Mice
J. Immunol., August 15, 2005; 175(4): 2401 - 2407.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Holscher, A. Holscher, D. Ruckerl, T. Yoshimoto, H. Yoshida, T. Mak, C. Saris, and S. Ehlers
The IL-27 Receptor Chain WSX-1 Differentially Regulates Antibacterial Immunity and Survival during Experimental Tuberculosis
J. Immunol., March 15, 2005; 174(6): 3534 - 3544.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. Artis, A. Villarino, M. Silverman, W. He, E. M. Thornton, S. Mu, S. Summer, T. M. Covey, E. Huang, H. Yoshida, et al.
The IL-27 Receptor (WSX-1) Is an Inhibitor of Innate and Adaptive Elements of Type 2 Immunity
J. Immunol., November 1, 2004; 173(9): 5626 - 5634.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bancroft, A. J.
Right arrow Articles by Grencis, R. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bancroft, A. J.
Right arrow Articles by Grencis, R. K.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS